The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / August / Your Genes May Shape Tumor Evolution
Oncology Biochemistry and molecular biology Genetics and epigenetics Precision medicine Molecular Pathology

Your Genes May Shape Tumor Evolution

Mouse study links inherited genetics to driver mutation selection, genome stability, and tumor evolution

08/19/2026 News 3 min read
  • Full Article
  • Summary
  • Report
  • Scorecard
  • Poll
  • Topic Commentary

Share

4 Topic Commentaries

Your Genes May Shape Tumor Evolution

Your Genes May Shape Tumor Evolution

  • Sarah J. Aitken
    Sarah J. Aitken, MBChB, PhD, FRCPath

    Pathology

    •

    Yale School of Medicine

    It looks like the genetics influence the ability for the cancer to arise in the first place, for the mutations to happen, and also for how a tumor then evolves in a particular individual and responds to treatment.

    Source
  • Christina Curtis
    Christina Curtis, PhD, MSc

    Cancer genomics

    •

    Stanford University School of Medicine

    Rather, we find that the path to tumor development is constrained by hereditary factors and immunity. This new result unearths a new class of biomarkers to forecast tumor progression and an entirely new way of understanding breast cancer origins.

    Source
  • Jian Carrot-Zhang
    Jian Carrot-Zhang, PhD

    Computational oncology

    •

    Memorial Sloan Kettering Cancer Center

    Since many of the tumor genetic changes we studied are already used to guide treatment decisions, understanding how inherited genetics influence these changes could open new doors for more personalized cancer care.

    Source
  • Robert B. Jenkins
    Robert B. Jenkins, MD, PhD

    Medical genetics and pathology

    •

    Mayo Clinic

    While we understand much of the biologic function of germline alterations within genes that code for proteins, we know very little about the biologic function of germline alterations outside of genes that code for proteins. In some way, these germline alterations interact with other mutations in cells to accelerate tumor formation.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.